Literature DB >> 9049141

Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut.

X Fu-Cheng1, Y Anini, J Chariot, N Castex, J P Galmiche, C Rozé.   

Abstract

Peptide YY (PYY) release in anaesthetized rats was studied during the 2 h following the intraduodenal administration of a semi-liquid meal of 21 kJ. Surgical and pharmacological manipulations were performed in order to analyse the mechanisms of PYY release. Postprandial PYY release was suppressed or strongly decreased by caecocolonectomy, truncal vagotomy, tetrodotoxin, hexamethonium, sensory denervation by perivagal capsaicin, and by the NO-synthase inhibitor L-N-arginine methyl ester, while atropine, adrenergic blockers, antagonists of type-A or type-B cholecystokinin (CCK) receptors or bombesin receptors had no effect. Comparing the digestive transit of the semi-liquid meal with the amount of PYY contained in the small bowel wall showed that nutrients had not reached the area rich in cells containing PYY by 30 min, the time at which there was a large PYY release in plasma. By 120 min, the meal front had travelled 72% of the small intestine length, just beginning to reach the PYY-rich part of the ileum. We conclude that the main postprandial PYY release studied in this model comes from ileal and colonic L-cells indirectly stimulated through a neural mechanism originating in the proximal gut and involving sensory vagal fibres, nicotinic synapses and NO release, while CCK and bombesin do not seem to be physiologically involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049141     DOI: 10.1007/s004240050316

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  21 in total

Review 1.  Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.

Authors:  Paige V Bauer; Sophie C Hamr; Frank A Duca
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

Review 2.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  The vagus nerve, food intake and obesity.

Authors:  Hans-Rudolf Berthoud
Journal:  Regul Pept       Date:  2008-03-25

Review 4.  Gastrointestinal hormones regulating appetite.

Authors:  Owais Chaudhri; Caroline Small; Steve Bloom
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.

Authors:  Edwin K Jackson; Stanton J Kochanek; Delbert G Gillespie
Journal:  Hypertension       Date:  2012-07-16       Impact factor: 10.190

Review 6.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

7.  NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.

Authors:  Xiao Zhu; Delbert G Gillespie; Edwin K Jackson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-14       Impact factor: 4.733

8.  Pathways and receptors involved in peptide YY induced contraction of rat proximal colonic muscle in vitro.

Authors:  L Ferrier; J P Segain; P Pacaud; C Cherbut; G Loirand; J P Galmiche; H M Blottière
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

9.  Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.

Authors:  C Ullmer; R Alvarez Sanchez; U Sprecher; S Raab; P Mattei; H Dehmlow; S Sewing; A Iglesias; J Beauchamp; K Conde-Knape
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.

Authors:  Edwin K Jackson; Zaichuan Mi
Journal:  Hypertension       Date:  2008-04-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.